Trending

Apollo Hospitals' share price jumps over 2% on demerger buzz

New listing plan lifts investor sentiment. But is the premium worth it?

New listing plan lifts investor sentiment. But is the premium worth it?Adobe Stock

Apollo Hospitals has grabbed the market’s attention — and how. The stock hit a fresh 52-week high of Rs 7,583, rallying over 2 per cent intraday today (July 1, 2025), as investors cheered its plans to carve out its digital and pharmacy business into a separate listed entity. The move, seen as a value unlocker, has given fresh legs to the stock that was already on a steady run.

What’s moving the stock

  • Big demerger move: Apollo is spinning off its digital health and pharmacy arm into a separate company. Existing shareholders will get shares in the new entity — a classic value-unlocking play.
  • Expansion story intact: The company plans to add 4,300 beds in the next few years, with Rs 6,000 crore earmarked for the task.

About Apollo Hospitals

Apollo Hospitals Enterprise is India’s largest private healthcare chain. With 70+ hospitals, 5,000+ pharmacies and its digital health platform Apollo 24|7, it’s a name that dominates the sector. From primary care to complex surgeries and telemedicine, Apollo has built an end-to-end healthcare ecosystem.

Below is a table summarising its fundamentals.

Metric Value
Market cap Rs 1.07 lakh crore
P/E ratio 74.3
P/B ratio 13.1
ROE 14.3 per cent
ROCE 19.1 per cent
Dividend yield 0.3 per cent
Book value Rs 570.6
EPS Rs 100.6

Value Research Online ratings

  • Overall: 3/5
  • Quality: 5/10
  • Growth: 7/10
  • Valuation: 4/10
  • Momentum: 7/10

What this means for investors

Apollo’s story is strong: earnings beat, growth plans and now a demerger catalyst. But at 72x earnings, it’s priced for perfection. If you’re in, stay watchful. If you’re out, maybe wait for a better entry point.

Serious about wealth? So are we.

Join thousands of smart investors who rely on Value Research Stock Advisor for expert-picked stocks, time-tested strategies and long-term discipline.

Stop guessing. Start growing. Check it out now: Value Research Stock Advisor.

Disclaimer: This is not a stock recommendation. This story was created with the assistance of artificial intelligence and is intended for informational purposes only. Please take it with a pinch of salt and do your own research or consult a financial advisor before making investment decisions.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


Other Categories